Sunday, September 13, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Earnings callYahoo Finance· February 18, 2026

Cinemark Q4 Earnings Call Highlights

View original at finance.yahoo.com
Cinemark Q4 Earnings Call Highlights Cinemark logo Key Points Cinemark reported a "post‑pandemic high" in 2025 with worldwide revenue of $3.1 billion, $578 million of adjusted EBITDA and an 18.6% adjusted EBITDA margin, while extinguishing over $700 million of COVID debt and returning $315 million to shareholders…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Cinemark delivered a 'post-pandemic high' in 2025 results

    80% confidence
  • U.S. recliner penetration is now about 72%

    80% confidence
  • 45 days is generally viewed as a reasonable target for theatrical windows, but key details remain including '45 days to what'

    80% confidence
  • Proceeds from alternative content in 2025 were more than double 2019 levels

    80% confidence
  • The company expects another year of moderate per-cap growth in 2026

    80% confidence
  • 2025 lacked a mega blockbuster that exceeded $500 million and had no major summer animated film

    80% confidence
  • There are indications that awareness of highly shortened windows may be affecting smaller movies and casual moviegoers

    80% confidence
  • Movie Club in the U.S. is up more than 50% versus 2019

    80% confidence
  • 2026 is expected to benefit from a robust lineup of compelling films and a volume of wide releases that appears poised to reach pre-pandemic levels

    80% confidence
  • For 2026, market share could normalize a bit due to more crowding in summer and year-end, which could increase capacity constraints

    80% confidence
  • About 10% of Cinemark's domestic circuit has two XD screens

    80% confidence
  • Domestic per caps were up 5% year-over-year in 2025, with around three points from pricing and about a point each from incidence and product mix

    80% confidence
  • Cinemark is using AI in areas such as pricing optimization, showtime optimization, app and software development, hiring, and guest services

    80% confidence
  • Premium enhanced formats represent about 15% of overall box office

    80% confidence
  • 2025's slate softness was largely the normal ebb and flow of the industry, not primarily structural

    80% confidence
  • Argentina's attendance has recovered to near pre-pandemic levels despite economic instability

    80% confidence
  • Cinemark delivered a 4% compound annual growth rate in domestic average ticket price over the past three years

    80% confidence
  • International capital spending is typically around $50 million to $60 million

    80% confidence
  • Alternative programming has exceeded 10% of Cinemark's box office for multiple consecutive years

    80% confidence
  • Cinemark expects stronger box office and attendance in 2026 to support operating leverage and margin expansion

    80% confidence
  • The company expects average ticket prices to increase modestly year-over-year in 2026

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Keeps Flowing as Enterprise Adoption and Government Contracts Validate the Bet
A late-August surge of nine-figure funding rounds (Socure, Stability AI, Generalist AI, Gatik, Regent Craft, Emerald AI, Owner) shows venture capital still pouring into AI infrastructure, identity/fintech, and autonomy, even as public-market sentiment stays jumpy — Palantir's stock fell 6% the same week it landed the Army's TITAN contract. UiPath's raised guidance and strong Q2 results, alongside efficiency breakthroughs like Multiverse Computing's model compression, point to real enterprise monetization catching up to the funding hype.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts record the same attribute (net_income) for JPMorgan Chase & Co. in the identical fiscal period (Q1 2026) and observation date (2026-03-31), but report values that differ by approximately 1 billion times: $16,494,000,000 vs $16.49. These cannot both be true simultaneously. The discrepancy suggests either a unit mismatch (e.g., one is total net income, the other earnings per share mislabeled as net_income), a decimal point error, or data entry corruption. For the same entity, attribute, and time period, only one value can be correct.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,280 source documents archived
Query this data → isubstrate.com